Seller
Visit
Buyer
Cliantha Trust
Focus Sector
Visit Health, a healthtech platform, recently announced the successful raise of over ₹250 crore through a combination of primary capital infusion and secondary purchase of shares held by Docprime Technologies, a wholly-owned subsidiary of PB Fintech, along with contributions from other promoters and employees.
This capital infusion is set to fuel the company’s ambitious growth strategy across three critical pillars: people, network, and technology.
“We are looking at using this fund for three main pillars of any company, which is people, network, and technology. So we would appreciate good, like-minded folks joining our team. And obviously, the network is going to play a very critical role in primary health care,” Vaibhav Singh, Co-Founder & MD of Visit Health stated in an interview with CNBC-TV18.
He emphasised the importance of expanding the network to include preferred doctors and clinics in Tier-II, III, and IV cities and enhancing technological capabilities to provide a seamless, cashless healthcare experience.
Visit Health’s commitment to bridging the gap in primary healthcare is further evident in its comprehensive service offerings. Singh highlighted that the platform covers all aspects of primary healthcare, which is essential for day-to-day health management before hospitalisation.
It has been a privilege to have worked with Shashwat, Vishal and the Khetal Team. Their strategic insights, deal making expertise network has been immensely valuable to Visit.

Mr. Anurag Prasad
(Co-founder – Visit) Visit & Cliantha Trust
Our Transactions and Clients
